MedPath

FARXIGA

These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA (dapagliflozin) tablets, for oral useInitial U.S. Approval: 2014

Approved
Approval ID

40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 3, 2023

Manufacturers
FDA

Cardinal Health 107, LLC

DUNS: 118546603

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DAPAGLIFLOZIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55154-6933
Application NumberNDA202293
Product Classification
M
Marketing Category
C73594
G
Generic Name
DAPAGLIFLOZIN
Product Specifications
Route of AdministrationORAL
Effective DateAugust 4, 2022
FDA Product Classification

INGREDIENTS (6)

MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
DAPAGLIFLOZIN PROPANEDIOLActive
Quantity: 10 mg in 1 1
Code: 887K2391VH
Classification: ACTIM
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

DAPAGLIFLOZIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55154-6932
Application NumberNDA202293
Product Classification
M
Marketing Category
C73594
G
Generic Name
DAPAGLIFLOZIN
Product Specifications
Route of AdministrationORAL
Effective DateAugust 4, 2022
FDA Product Classification

INGREDIENTS (6)

DAPAGLIFLOZIN PROPANEDIOLActive
Quantity: 5 mg in 1 1
Code: 887K2391VH
Classification: ACTIM
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
anhydrous lactoseInactive
Code: 3SY5LH9PMK
Classification: IACT
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FARXIGA - FDA Drug Approval Details